Data / Research funding / Maryland / Emergent Product Development Gaithersbur
Emergent Product Development Gaithersbur: 4 NIH awards ($5.3M), fiscal years 2021 to 2026
Emergent Product Development Gaithersbur in Gaithersburg, MD is funded under 4 NIH awards ($5.3M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- NIH institution profile
- 3191901
- State
- Maryland
- Note
- NIH gives no UEI for this institution, so NSF awards are not matched.
Awards
4 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Development of an Anthrax Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $2,562,540 | September 25, 2008 | July 7, 2021 | PARK, SUKJOON | reporter.nih.gov |
| Development of Monoclonal Antibody Therapeutics for Anthrax | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $1,448,422 | September 1, 2008 | August 31, 2012 | JOHNSON, VIRGINIA G. | reporter.nih.gov |
| Development of Human Anthrax Immune Globulin | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $749,260 | September 28, 2007 | December 31, 2011 | ROBERT, HOPKINS | reporter.nih.gov |
| DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $545,686 | August 28, 2014 | February 29, 2024 | LEMIALE, LAURENCE | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2023 | 1 | $476,408 | 0 | $0 |
| 2022 | 1 | $69,278 | 0 | $0 |
| 2021 | 3 | $4,760,222 | 0 | $0 |
Topics of its NIH awards
- Anthrax
- Emerging Infectious Diseases
- Immunization
- Infectious Diseases
- Orphan Drug
- Rare Diseases
- Biodefense
- Clinical Research
- Prevention
- Vaccine Related
- Biotechnology
- Biodefense and Related Countermeasures
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.